Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses

Journal of the American Association of Nurse Practitioners

Volumn 27, Issue 9, 2015, Pages 530-542

  Mccormick, Ursula ^a   Murray, Bethany ^b   Mcnew, Brittany ^a  

^a Medical Services   (United States)

^b Indiana School of Nursing   (United States)

Author keywords

Bipolar disorder; Managed care; Mental health; Nurse practitioners; Primary care

Indexed keywords

BIPOLAR DISORDER; HUMAN; NURSE PRACTITIONER; NURSING; NURSING PRACTICE; PSYCHIATRIC NURSING;

BIPOLAR DISORDER; HUMANS; NURSE PRACTITIONERS; PRACTICE PATTERNS, NURSES'; PSYCHIATRIC NURSING;

EID: 84941038741     PISSN: 23276886     EISSN: 23276924     Source Type: Journal    
DOI: 10.1002/2327-6924.12275     Document Type: Review

References (91)

1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychiatric Association.
2. Amit, B. H., & Weizman, A. (2012). Antidepressant treatment for bipolar depression: An update. Depression Research and Treatment, 2012, 684725. doi:10.1155/2012/684725.
3. Baldessarini, R. J., Salvatore, P., Khalsa, H. M., Gebre-Medhin, P., Imaz, H., Gonzalez-Pinto, A., ... Tohen, M. (2010). Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disorders, 12, 264-270. doi: 10.1111/j.1399-5618.2010.00812.x.
4. Bauer, M. S., McBride, L., Williford, W. O., Glick, H., Kinosian, B., Altshuler, L., ... Sajatovic, M. (2006). Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs. Psychiatric Services, 57(7), 937-945. doi: 10.1176/appi.ps.57.7.937.
5. Benazzi, F. (2007). Bipolar II disorder: Epidemiology, diagnosis and management. CNS Drugs, 21(9), 727-740.
6. Bowden, C. L., Brugger, A. M., Swann, A. C., Calabrese, J. R., Janicak, P. G., Petty, F., ... Frazer, A. (1994). Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association, 271, 918-924.
7. Calabrese, J. R., Keck, P. E., Jr., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., ... Mullen, J. (2005). A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. American Journal of Psychiatry, 162, 1351-1360. doi: 10.1176/appi.ajp.162.7.1351.
8. Cerimele, J. M., Chwastiak, L. A., Chan, Y. F., Harrison, D. A., & Unutzer, J. (2013). The presentation, recognition and management of bipolar depression in primary care. Journal of General Internal Medicine, 28, 1648-1656. doi:10.1007/s11606-013-2545-7.
9. Chen, Y. W., & Dilsaver, S. C. (1996). Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders. Biological Psychiatry, 39, 896-899. doi: 10.1016/0006-3223(95)00295-2.
10. Chen, C. H., & Lin, S. K. (2012). Carbamazepine treatment of bipolar disorder: A retrospective evaluation of naturalistic long-term outcomes. BMC Psychiatry, 12, 47. doi:10.1186/1471-244X-12-47.
11. Chung, H., Culpepper, L., deWester, J. N., deWester, J. N., Grieco, R., Kaye, N. S., ... Ross, R. (2007). Challenges in recognition, clinical management, and treatment of bipolar disorders at the interface of psychiatric medicine and primary care. Current Psychiatry, 6(11). Retrieved from http://www.currentpsychiatry.com/education-center/education-center/article/challenges-in-recognition-clinical-management-and-treatment-of-bipolar-disorder-at-the-interface-of-psychiatric-medicine-and-primary-care/a3b717e8fc79bbb15d27bf9352f872f5.html.
12. Colom, F., Vieta, E., Sanchez-Moreno, J., Goikolea, J. M., Popova, E., Bonnin, C. M., & Scott, J. (2009). Psychoeducation for bipolar II disorder: An exploratory, 5-year outcome subanalysis. Journal of Affective Disorders, 112(1-3), 30-35. doi: 10.1016/j.jad.2008.03.023.
13. Connolly, K. R., & Thase, M. E. (2011). The clinical management of bipolar disorder: A review of evidence-based guidelines. Primary Care Companion for CNS Disorders, 13, pii: PCC.10r01097. doi:10.4088/PCC.10r01097.
14. Crump, C., Sundquist, K., Winkleby, M. A., & Sundquist, J. (2013). Comorbidities and mortality in bipolar disorder: A Swedish national cohort study. JAMA Psychiatry, 70, 931-939. doi:1714400[pii];10.1001/jamapsychiatry.2013.1394.
15. Culpepper, L. (2010). The role of primary care clinicians in diagnosing and treating bipolar disorder. Primary Care Companion to the Journal of Clinical Psychiatry, 12(Suppl 1), 4-9. doi:10.4088/PCC.9064su1c.01.
16. Derry, S., & Moore, R. A. (2007). Atypical antipsychotics in bipolar disorder: Systematic review of randomised trials. BMC Psychiatry, 7, 40. doi:1471-244X-7-40.
17. Devulapalli, K. K., Ignacio, R. V., Weiden, P., Cassidy, K. A., Williams, T. D., Safavi, R., ... Sajatovic, M. (2010). Why do persons with bipolar disorder stop their medication? Psychopharmacology Bulletin, 43, 5-14. Retrieved from PM:21150842.
18. Dilsaver, S. C. (2011). An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009. Journal of Affective Disorders, 129, 79-83. doi: 10.1016/j.jad.2010.08.030.
19. Dodd, S., & Berk, M. (2004). The pharmacology of bipolar disorder during pregnancy and breastfeeding. Expert Opinion on Drug Safety, 3, 221-229. doi:10.1517/eods.3.3.221.31074.
20. Frank, E., Swartz, H. A., & Boland, E. (2007). Interpersonal and social rhythm therapy: An intervention addressing rhythm dysregulation in bipolar disorder. Dialogues in Clinical Neuroscience, 9, 325-332.
21. Frank, E., Kupfer, D. J., Thase, M. E., Mallinger, A. G., Swartz, H. A., Fagiolini, A. M., ... Monk, T. (2005). Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Archives of General Psychiatry, 62, 996-1004. doi: 10.1001/archpsyc.62.9.996.
22. Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., ... Post, R. M. (2000). A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. Journal of Clinical Psychopharmacology, 20, 607-614.
23. Gaynes, B. N., DeVeaugh-Geiss, J., Weir, S., Gu, H., MacPherson, C., Schulberg, H. C., ... Rubinow, D. R. (2010). Feasibility and diagnostic validity of the M-3 checklist: A brief, self-rated screen for depressive, bipolar, anxiety, and post-traumatic stress disorders in primary care. Annals of Family Medicine, 8, 160-169. doi: 10.1370/afm.1092.
24. Geddes, J. R., Burgess, S., Hawton, K., Jamison, K., & Goodwin, G. M. (2004). Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. American Journal of Psychiatry, 161, 217-222.
25. Geddes, J. R., Calabrese, J. R., & Goodwin, G. M. (2009). Lamotrigine for treatment of bipolar depression: Independent meta-analysis and meta-regression of individual patient data from five randomised trials. British Journal of Psychiatry, 194, 4-9. doi: 10.1192/bjp.bp.107.048504.
26. Geddes, J. R., Goodwin, G. M., Rendell, J., Azorin, J. M., Cipriani, A., Ostacher, M. J., ... Juszczak, E. (2010). Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial. Lancet, 375, 385-395. doi: 10.1016/S0140-6736(09)61828-6.
27. Geddes, J. R., & Miklowitz, D. J. (2013). Treatment of bipolar disorder. Lancet, 381, 1672-1682. doi: 10.1016/S0140-6736(13)60857-0.
28. Gill, J. M., Chen, Y. X., Grimes, A., & Klinkman, M. S. (2012). Using electronic health record-based tools to screen for bipolar disorder in primary care patients with depression. Journal of the American Board of Family Medicine, 25(3), 283-290. doi: 10.3122/jabfm.2012.03.110217.
29. Goldberg, J. F. (2010). Differential diagnosis of bipolar disorder. CNS Spectrums, 15(2 Suppl 3), 4-7.
30. Grant, B. F., Stinson, F. S., Hasin, D. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Huang, B. (2005). Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 66, 1205-1215.
31. Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Moller, H. J., & Kasper, S. (2009). The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2009 on the treatment of mania. World Journal of Biological Psychiatry, 10, 85-116. doi: 10.1080/15622970902823202.
32. Hassan, M., & Lage, M. J. (2009). Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge. American Journal of Health-System Pharmacy, 66, 358-365. doi: 10.2146/ajhp080374.
33. Hirschfeld, R. M. (2007). Screening for bipolar disorder. American Journal of Managed Care, 13(7 Suppl), S164-S169.
34. Hirschfeld, R. M., Bowden, C. L., & Gitlin, M. J. (2002). Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association. Retrieved from http://dbsanca.org/docs/APA_Bipolar_Guidelines.1783155.pdf.
35. Hirschfeld, R. M., Williams, J. B., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck, P. E., Jr., ... Zajecka, J. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. American Journal of Psychiatry, 157, 1873-1875.
36. Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009). Medication adherence: Its importance in cardiovascular outcomes. Circulation, 119, 3028-3035. doi: 10.1161/CIRCULATIONAHA.108.768986.
37. Hoyle, S., Elliott, L., & Comer, L. (2015). Available screening tools for adults suffering from bipolar affective disorder in primary care: An integrative literature review. Journal of the American Association of Nurse Practitioners, 27, 280-289.
38. Jones, S., Mulligan, L. D., Law, H., Dunn, G., Welford, M., Smith, G., & Morrison, A. P. (2012). A randomised controlled trial of recovery focused CBT for individuals with early bipolar disorder. BMC Psychiatry, 12, 204. doi:1471-244X-12-204.
39. Judd, L. L., Akiskal, H. S., Schettler, P. J., Coryell, W., Endicott, J., Maser, J. D., ... Keller, M. B. (2003). A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Archives of General Psychiatry, 60, 261-269.
40. Kardas, P., Lewek, P., & Matyjaszczyk, M. (2013). Determinants of patient adherence: A review of systematic reviews. Frontiers in Pharmacology, 4, 91. doi:10.3389/fphar.2013.00091.
41. Kelly, T., Douglas, L., Denmark, L., Brasuell, G., & Lieberman, D. Z. (2013). The high prevalence of obstructive sleep apnea among patients with bipolar disorders. Journal of Affective Disorders, 151(1), 54-58. doi:S0165-0327(13)00426-6[pii];10.1016/j.jad.2013.05.047.
42. Kessing, L. V., Hellmund, G., Geddes, J. R., Goodwin, G. M., & Andersen, P. K. (2011). Valproate v. lithium in the treatment of bipolar disorder in clinical practice: Observational nationwide register-based cohort study. British Journal of Psychiatry, 199, 57-63. doi:10.1192/bjp.bp.110.084822.
43. Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry, 66(1), 17-31.
44. Kessler, R. C., & Ustun, T. B. (2004). The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). International Journal of Methods in Psychiatric Research, 13, 93-121.
45. Ketter, T. A. (2010). Diagnostic features, prevalence, and impact of bipolar disorder. Journal of Clinical Psychiatry, 71, e14. doi:10.4088/JCP.8125tx11c.
46. Kilbourne, A. M., Cornelius, J. R., Han, X., Pincus, H. A., Shad, M., Salloum, I., ... Haas, G. L. (2004). Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disorders, 6, 368-373. doi:10.1111/j.1399-5618.2004.00138.x.
47. Krishnan, K. R. (2005). Psychiatric and medical comorbidities of bipolar disorder. Psychosomatic Medicine, 67, 1-8. doi: 10.1097/01.psy.0000151489.36347.18.
48. Laakso, L. J. (2012). Motivational interviewing: Addressing ambivalence to improve medication adherence in patients with bipolar disorder. Issues in Mental Health Nursing, 33, 8-14. doi:10.3109/01612840.2011.618238.
49. Lage, M. J., & Hassan, M. K. (2009). The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: A retrospective study. Annals of General Psychiatry, 8, 7. doi:10.1186/1744-859X-8-7.
50. Lew, K. H., Chang, E. Y., Rajagopalan, K., & Knoth, R. L. (2006). The effect of medication adherence on health care utilization in bipolar disorder. Managed Care Interface, 19, 41-46.
51. Loebel, A., Cucchiaro, J., Silva, R., Kroger, H., Hsu, J., Sarma, K., & Sachs, G. (2014a). Lurasidone monotherapy in the treatment of bipolar I depression: A randomized, double-blind, placebo-controlled study. American Journal of Psychiatry, 171, 160-168. doi:10.1176/appi.ajp.2013.13070984.
52. Loebel, A., Cucchiaro, J., Silva, R., Kroger, H., Sarma, K., Xu, J., & Calabrese, J. R. (2014b). Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: A randomized, double-blind, placebo-controlled study. American Journal of Psychiatry, 171, 169-177. doi:10.1176/appi.ajp.2013.13070985.
53. Manning, J. S. (2010). Tools to improve differential diagnosis of bipolar disorder in primary care. Primary Care Companion to the Journal of Clinical Psychiatry, 12(Suppl 1), 17-22. doi:10.4088/PCC.9064su1c.03.
54. Martinez, J. M., Russell, J. M., & Hirschfeld, R. M. (1998). Tolerability of oral loading of divalproex sodium in the treatment of mania. Depression and Anxiety, 7, 83-86. doi:10.1002/(SICI)1520-6394(1998)7:2<83::AID-DA6>3.0.CO;2-6.
55. McCombs, J. S., Ahn, J., Tencer, T., & Shi, L. (2007). The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: A 6-year retrospective analysis. Journal of Affective Disorders, 97(1-3), 171-179. doi: 10.1016/j.jad.2006.06.018.
56. McIntyre, R. S. (2009). Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: The UNITE global survey. Journal of Clinical Psychiatry, 70(Suppl 3), 5-11. doi: 10.4088?JCP.7075su1c.02.
57. McKenna, K., Koren, G., Tetelbaum, M., Wilton, L., Shakir, S., Diav-Citrin, O., ... Einarson, A. (2005). Pregnancy outcome of women using atypical antipsychotic drugs: A prospective comparative study. Journal of Clinical Psychiatry, 66, 444-449.
58. Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M., Petukhova, M., & Kessler, R. C. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Archives of General Psychiatry, 64, 543-552. doi: 10.1001/archpsyc.64.5.543.
59. Miller, K. (2006). Bipolar disorder: Etiology, diagnosis, and management. Journal of the American Association of Nurse Practitioners, 18, 368-373. 10.1111/j.1745-7599.2006.00148.x.
60. Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. Journal of Clinical Hypertension, 10, 348-354.
61. National Collaborating Centre for Mental Health (UK). (2006). Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. Living with bipolar disorder: Interventions and lifestyle advice. British Psychological Society. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK55353/
62. Nierenberg, A. A., Friedman, E. S., Bowden, C. L., Sylvia, L. G., Thase, M. E., Ketter, T., ... Calabrese, J. R. (2013). Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: A randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. American Journal of Psychiatry, 170, 102-110. doi: 10.1176/appi.ajp.2012.112060751.
63. Pacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., Licht, R. W., ... Vieta, E. (2013). The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. American Journal of Psychiatry, 170, 1249-1262. doi:10.1176/appi.ajp.2013.13020185.
64. Perlis, R. H. (2007). Treatment of bipolar disorder: The evolving role of atypical antipsychotics. American Journal of Managed Care, 13(7 Suppl), S178-S188. Retrieved from PM:18041879.
65. Price, L. H., & Heninger, G. R. (1994). Lithium in the treatment of mood disorders. New England Journal of Medicine, 331, 591-598. doi:10.1056/NEJM199409013310907.
66. Price, A. L., & Marzani-Nissen, G. R. (2012). Bipolar disorders: A review. American Family Physician, 85, 483-493. doi:d10089. Retrieved from PM:22534227.
67. Rascati, K. L., Richards, K. M., Ott, C. A., Goddard, A. W., Stafkey-Mailey, D., Alvir, J., ... Mychaskiw, M. (2011). Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder. Psychiatric Services, 62, 1032-1040. doi: 10.1176/appi.ps.62.9.1032.
68. Reinares, M., Colom, F., Sanchez-Moreno, J., Torrent, C., Martinez-Aran, A., Comes, M., ... Vieta, E. (2008). Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial. Bipolar Disorders, 10, 511-519. doi:10.1155/2013/548349.
69. Sasdelli, A., Lia, L., Luciano, C. C., Nespeca, C., Berardi, D., & Menchetti, M. (2013). Screening for bipolar disorder symptoms in depressed primary care attenders: comparison between Mood Disorder Questionnaire and Hypomania Checklist (HCL-32). Psychiatry Journal, 2013, 548349. doi:10.1155/2013/548349.
70. Scott, J., Colom, F., & Vieta, E. (2007). A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders. International Journal of Neuropsychopharmacology, 10, 123-129. doi: 10.1017/S1461145706006900.
71. Sidor, M. M., & Macqueen, G. M. (2011). Antidepressants for the treatment of bipolar depression: A systematic review and meta-analysis. Journal of Clinical Psychiatry, 72(2), 156-167. doi:10.4088/JCP.09r05385gre.
72. Smith, L. A., Cornelius, V., Warnock, A., Tacchi, M. J., & Taylor, D. (2007). bipolar mania: A systematic review and meta-analysis of co-therapy vs. monotherapy. Acta Psychiatrica Scandinavica, 115, 12-20. doi: 10.1111/j.1600-0447.2006.00912.x.
73. Soreca, I., Levenson, J., Lotz, M., Frank, E., & Kupfer, D. J. (2012). Sleep apnea risk and clinical correlates in patients with bipolar disorder. Bipolar Disorders, 14(6), 672-676. doi:10.1111/j.1399-5618.2012.01044.x.
74. Sublette, M. E., Carballo, J. J., Moreno, C., Galfalvy, H. C., Brent, D. A., Birmaher, B., ...Oquendo, M. A. (2009). Substance use disorders and suicide attempts in bipolar subtypes. Journal of Psychiatric Research, 43(3), 230-238. doi:S0022-3956(08)00114-3[pii];10.1016/j.jpsychires.2008.05.001.
75. Suppes, T., Datto, C., Minkwitz, M., Nordenhem, A., Walker, C., & Darko, D. (2010). Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of bipolar depression. Journal of Affective Disorders, 121(1-2), 106-115. doi: 10.1016/j.jad.2009.10.007.
76. Tatum, W. O. (2006). Use of antiepileptic drugs in pregnancy. Expert Review of Neurotherapeutics, 6, 1077-1086. doi:10.1586/14737175.6.7.1077.
77. Thase, M. E., Macfadden, W., Weisler, R. H., Chang, W., Paulsson, B., Khan, A., & Calabrese, J. R. (2006). Efficacy of quetiapine monotherapy in bipolar I and II depression: A double-blind, placebo-controlled study (the BOLDER II study). Journal of Clinical Psychopharmacology, 26(6), 600-609. doi:10.1097/01.jcp.0000248603.76231.b7.
78. The Management of Bipolar Disorder Working Group. (2010). VA/DoD clinical practice guidelines for management of bipolar disorder in adults Washington, DC: Department of Veterans Affairs, Department of Defense.
79. Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., ... Breier, A. (2003). Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Archives of General Psychiatry, 60, 1079-1088. doi:10.1001/archpsyc.60.11.1079.
80. Tondo, L., Baldessarini, R. J., Vazquez, G., Lepri, B., & Visioli, C. (2013). Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders. Acta Psychiatrica Scandinavica, 127, 355-364. doi:10.1111/acps.12023.
81. Tondo, L., Isacsson, G., & Baldessarini, R. (2003). Suicidal behaviour in bipolar disorder: Risk and prevention. CNS Drugs, 17, 491-511.
82. Valente, S. M., & Kennedy, B. L. (2010). End the bipolar tug-of-war. Nurse Practitioner, 35, 36-45. doi:10.1097/01.NPR.0000367933.64526.3e.
83. Vazquez, G., Tondo, L., & Baldessarini, R. J. (2011). Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: A meta-analytic review. Pharmacopsychiatry, 44, 21-26. doi:10.1055/s-0030-1265198.
84. Vieta, E., & Goikolea, J. M. (2005). Atypical antipsychotics: Newer options for mania and maintenance therapy. Bipolar Disorders, 7(Suppl 4), 21-33. doi:10.1111/j.1399-5618.2005.00212.x.
85. Vieta, E., Gunther, O., Locklear, J., Ekman, M., Miltenburger, C., Chatterton, M. L., ... Paulsson, B. (2011). Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: A meta-analysis of randomized controlled trials. International Journal of Neuropsychopharmacology, 14, 1029-1049. doi: 10.1017/S1461145711000885.
86. Vieta, E., & Valenti, M. (2013). Pharmacological management of bipolar depression: treatment, maintenance, and prophylaxis. CNS Drugs, 27, 515-529. doi:10.1007/s40263-013-0073-y.
87. Weisler, R. H., Kalali, A. H., & Ketter, T. A. (2004). A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. Journal of Clinical Psychiatry, 65, 478-484. Retrieved from PM:15119909.
88. Weisler, R. H., Keck, P. E., Jr., Swann, A. C., Cutler, A. J., Ketter, T. A., & Kalali, A. H. (2005). Extended-release carbamazepine capsules as monotherapy for mania in bipolar disorder: A multicenter, randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychiatry, 66, 323-330.
89. Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., ... Berk, M. (2013). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2013. Bipolar Disorders, 15, 1-44. doi:10.1111/bdi.12025.
90. Zeber, J. E., Copeland, L. A., Good, C. B., Fine, M. J., Bauer, M. S., & Kilbourne, A. M. (2008). Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. Journal of Affective Disorders, 107, 53-62. doi:10.1016/j.jad.2007.07.026.
91. Zolnierek, K. B., & Dimatteo, M. R. (2009). Physician communication and patient adherence to treatment: A meta-analysis. Medical Care, 47(8), 826-834. doi:10.1097/MLR.0b013e31819a5acc.